USANA Health Sciences, Inc. (USNA)

NYSE: USNA · Real-Time Price · USD

14.26

+0.22 (1.57%)

At close: Sep 24, 2026, 4:00 PM EDT

14.24

-0.02 (-0.14%)

After-hours: Sep 24, 2026, 7:30 PM EDT

USANA Health Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Net Income	-22.16	10.76	42.03	63.79	69.35	116.51
Depreciation & Amortization	38.81	39.7	22.23	20.4	21.41	22.19
Loss (Gain) From Sale of Assets	-2.1	-2.09	0	0.01	0.14	0.06
Asset Writedown & Restructuring Costs	36.1	6.97	-	-	-	-
Stock-Based Compensation	14.18	13.83	14.56	14.6	13.33	14.3
Other Operating Activities	-7.25	-3.74	-4.82	-0.15	-1.1	1.23
Change in Inventory	-12.28	-34.69	-2.12	2.35	15.8	-14.7
Change in Accounts Payable	-2.47	5.2	-1.27	-0.43	-2.66	-4.57
Change in Other Net Operating Assets	-14.34	-13.6	-9.62	-29.92	-12.37	-13.79
Operating Cash Flow	27.73	22.35	60.99	70.64	103.9	121.23
Operating Cash Flow Growth	-56.00%	-63.36%	-13.66%	-32.01%	-14.29%	-24.42%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Capital Expenditures	-11.79	-13.82	-10.07	-14.49	-10.4	-12.76
Sale of Property, Plant & Equipment	3.97	3.91	0.06	0.02	0.01	0.02
Cash Acquisitions	-	-	-203.34	-	-6.53	-
Other Investing Activities	-0.92	-0.21	0.26	2.5	4.56	-1.44
Investing Cash Flow	-8.74	-10.13	-213.09	-11.98	-12.37	-14.19

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Short-Term Debt Issued	-	17.6	23.69	1.54	11	-
Total Debt Issued	25	17.6	23.69	1.54	11	-
Short-Term Debt Repaid	-	-26.6	-1.47	-0.75	-11	-
Total Debt Repaid	-25	-26.6	-1.47	-0.75	-11	-
Net Debt Issued (Repaid)	-	-9	22.22	0.79	-	-
Repurchase of Common Stock	-2.45	-29.85	-12.67	-14.69	-30.09	-181.41
Other Financing Activities	-2.75	-1.75	-	-0.34	-	-
Financing Cash Flow	-5.19	-40.6	9.55	-14.24	-30.09	-181.41

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Foreign Exchange Rate Adjustments	3.59	5.11	-6.19	-2.5	-13.78	2.09
Net Cash Flow	17.38	-23.27	-148.74	41.93	47.67	-72.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Free Cash Flow	15.93	8.53	50.92	56.15	93.5	108.46
Free Cash Flow Growth	-68.75%	-83.26%	-9.31%	-39.95%	-13.79%	-25.36%
Free Cash Flow Margin	1.75%	0.92%	5.96%	6.10%	9.36%	9.14%
Free Cash Flow Per Share	0.87	0.46	2.66	2.90	4.84	5.33
Levered Free Cash Flow	49.13	36.85	63.1	61.35	104.19	112.81
Unlevered Free Cash Flow	49.39	37.37	63.28	61.51	104.31	112.84

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Cash Interest Paid	0.47	0.66	0.08	0.07	0.05	0.01
Cash Income Tax Paid	34.6	37.18	40.4	42.33	45.75	59.33
Change in Working Capital	-29.86	-43.08	-13	-28	0.77	-33.06

SEC Filings: 10-K · 10-Q